AstraZeneca Sees Bright Future For Registry-Based Randomized Clinical Trials

 
• By Bridget Silverman

AZ’s DAPA-MI trial showed the feasibility of R-RCT designs to support new indications in drug development and more established uses to inform medical practice.

Registry-based randomized clinical trials aim to use the wealth of real-world data collected by patient registries. (Shutterstock)

More from Real-World Evidence

More from Geography